Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,741 | 61,729 | 70,946 | 81,053 | 140,717 |
| Receivables | 3,330 | 1,864 | 19 | 21 | 446 |
| TOTAL | $105,492 | $84,285 | $90,783 | $104,884 | $152,521 |
| Non-Current Assets | |||||
| PPE Net | 1,110 | 1,097 | 1,211 | 843 | 581 |
| Other Non-Current Assets | 2,512 | 9,669 | 13,612 | 621 | 622 |
| TOTAL | $3,622 | $10,766 | $14,823 | $1,464 | $1,203 |
| Total Assets | $109,114 | $95,051 | $105,606 | $106,348 | $153,724 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 906 | 707 | 4,417 | 156 | 2,008 |
| Accrued Expenses | 10,846 | 8,763 | 9,909 | 9,109 | 8,906 |
| TOTAL | $12,526 | $9,483 | $20,856 | $15,809 | $18,123 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 13 | 6,530 | 6,544 | 7,209 |
| Other Non-Current Liabilities | 1,578 | 0 | 146,416 | 126,183 | 0 |
| TOTAL | $1,578 | $4 | $181,556 | $167,837 | $48,230 |
| Total Liabilities | $14,104 | $9,487 | $202,412 | $183,646 | $66,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,421 | 1,083 | 950 | 883 | 879 |
| Common Shares | 182 | 161 | 143 | 132 | 132 |
| Retained earnings | -684,125 | -566,329 | -712,442 | -657,997 | -492,700 |
| TOTAL | $95,010 | $85,564 | $-96,806 | $-77,298 | $87,371 |
| Total Liabilities And Equity | $109,114 | $95,051 | $105,606 | $106,348 | $153,724 |